Origin Therapeutics Announces New Director
September 09, 2022 08:00 ET
|
Origin Therapeutics Holdings Inc.
Vancouver, B.C., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE: ORIG) (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics industry-focused...
Origin Therapeutics adds Clairvoyant Therapeutics to its Portfolio
July 07, 2022 08:00 ET
|
Origin Therapeutics Holdings Inc.
Vancouver, B.C., July 07, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE:ORIG) (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics industry-focused...
UPDATE - Origin Therapeutics Applauds Incoming Decriminalization for Potential to Reduce Stigma
June 14, 2022 13:42 ET
|
Origin Therapeutics Holdings Inc.
Vancouver, B.C., June 14, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE:ORIG) (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics industry-focused...
Origin Therapeutics Applauds Incoming Decriminalization for Potential to Reduce Stigma
June 14, 2022 08:00 ET
|
Origin Therapeutics Holdings Inc.
Vancouver, B.C., June 14, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE:ORIG) (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics industry-focused...
Origin Therapeutics to Begin Trading on the CSE Under the Symbol “ORIG”
June 02, 2022 08:00 ET
|
Origin Therapeutics Holdings Inc.
Vancouver, B.C., June 02, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics industry-focused investment issuer,...
Origin Therapeutics’ Portfolio Company, Dimensions, to Launch Psychedelic Healing Retreat
May 17, 2022 08:00 ET
|
Origin Therapeutics Holdings Inc.
Vancouver, B.C. & Toronto, ON, May 17, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics industry-focused...
Origin Therapeutics Portfolio Company TripSitter Joins Forces with Reconscious Medical, Expands to 23 States
March 29, 2022 08:00 ET
|
Origin Therapeutics Holdings Inc.
Vancouver, B.C. & Toronto, ON, March 29, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”), an actively managed, psychedelic-focused investment...
Origin Therapeutics Sponsoring Microdose Psychedelic Capital Conference
March 23, 2022 09:00 ET
|
Origin Therapeutics Holdings Inc.
Vancouver, British Columbia, March 23, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”), an actively managed, psychedelic-focused investment...
Origin Therapeutics Applauds Health Canada Amendment of Special Access Program for Psychedelics
January 27, 2022 08:00 ET
|
Origin Therapeutics Holdings Inc.
Vancouver, British Columbia, Jan. 27, 2022 (GLOBE NEWSWIRE) -- January 27, 2022 – Origin Therapeutics Holdings Inc. (CSE: ORIG Proposed) (the “Company” or “Origin Therapeutics”) an actively managed...
Origin Therapeutics Portfolio Company Posts Strong 2021 Following Successful Miami Conference
January 20, 2022 08:00 ET
|
Origin Therapeutics Holdings Inc.
Vancouver, British Columbia, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE: ORIG Proposed) (the “Company” or “Origin Therapeutics”), an actively managed,...